Malaria

Photo
03.08.2021 • News

BioNTech Developing new Malaria Vaccine

BioNTech has launched a new project aimed at developing what it hopes will be a well-tolerated and highly effective malaria vaccine for the African continent. The Mainz, Germany-based company, which developed a Covid-19 vaccine together with Pfizer in only ten months, said its goal is to produce the malaria vaccine locally.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.